KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EBT: 2009-2024

Historic EBT for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • Quest Diagnostics' EBT rose 10.81% to $328.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 15.63%. This contributed to the annual value of $1.2 billion for FY2024, which is 3.98% up from last year.
  • Per Quest Diagnostics' latest filing, its EBT stood at $1.2 billion for FY2024, which was up 3.98% from $1.1 billion recorded in FY2023.
  • In the past 5 years, Quest Diagnostics' EBT registered a high of $2.6 billion during FY2021, and its lowest value of $1.1 billion during FY2023.
  • For the 3-year period, Quest Diagnostics' EBT averaged around $1.2 billion, with its median value being $1.2 billion (2024).
  • As far as peak fluctuations go, Quest Diagnostics' EBT surged by 75.09% in 2020, and later crashed by 52.48% in 2022.
  • Over the past 5 years, Quest Diagnostics' EBT (Yearly) stood at $1.9 billion in 2020, then spiked by 37.95% to $2.6 billion in 2021, then crashed by 52.48% to $1.2 billion in 2022, then fell by 8.50% to $1.1 billion in 2023, then rose by 3.98% to $1.2 billion in 2024.